Long-term pioglitazone use in MASLD patients: insights from a multicentric preliminary study (2026)
Subjects: ESTUDOS RETROSPECTIVOS, HOSPITAIS PÚBLICOS, HEPATOPATIAS, BIOMARCADORES
ABNT
PEREIRA, Isabel Veloso Alves et al. Long-term pioglitazone use in MASLD patients: insights from a multicentric preliminary study. Clinics, v. 80, 2026Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/90858. Acesso em: 25 abr. 2026.APA
Pereira, I. V. A., Oliveira, A. B. S. de, Zitelli, P. M. Y., Barbieri, L. A., Cardoso, A. C., Monteiro, M. J. de S. D., et al. (2026). Long-term pioglitazone use in MASLD patients: insights from a multicentric preliminary study. Clinics, 80. doi:10.1016/j.clinsp.2025.100737NLM
Pereira IVA, Oliveira ABS de, Zitelli PMY, Barbieri LA, Cardoso AC, Monteiro MJ de SD, Oliveira JS de, Stefano JT, Altikes R, Oliveira CPMS de. Long-term pioglitazone use in MASLD patients: insights from a multicentric preliminary study [Internet]. Clinics. 2026 ; 80[citado 2026 abr. 25 ] Available from: https://observatorio.fm.usp.br/handle/OPI/90858Vancouver
Pereira IVA, Oliveira ABS de, Zitelli PMY, Barbieri LA, Cardoso AC, Monteiro MJ de SD, Oliveira JS de, Stefano JT, Altikes R, Oliveira CPMS de. Long-term pioglitazone use in MASLD patients: insights from a multicentric preliminary study [Internet]. Clinics. 2026 ; 80[citado 2026 abr. 25 ] Available from: https://observatorio.fm.usp.br/handle/OPI/90858
